NDC 0703-4685
mitoXANTRONE
Mitoxantrone
mitoXANTRONE is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category.  It is labeled and distributed by Teva Parenteral Medicines, Inc.. The primary component is Mitoxantrone Hydrochloride.
| Product ID | 0703-4685_031f9934-217e-40c4-b623-92a44b5831ac | 
| NDC | 0703-4685 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | mitoXANTRONE | 
| Generic Name | Mitoxantrone | 
| Dosage Form | Injection, Solution, Concentrate | 
| Route of Administration | INTRAVENOUS | 
| Marketing Start Date | 2006-04-11 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA077356 | 
| Labeler Name | Teva Parenteral Medicines, Inc. | 
| Substance Name | MITOXANTRONE HYDROCHLORIDE | 
| Active Ingredient Strength | 2 mg/mL | 
| Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 |